Luxist Web Search

Search results

1. Results From The WOW.Com Content Network

2. Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates

   www.aol.com/news/royalty-pharma-rprx-tops-q2...

   Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.28% and 2.37%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3. Royalty Pharma (RPRX) Q2 Earnings and Revenues Surpass ... - AOL

   www.aol.com/news/royalty-pharma-rprx-q2-earnings...

   Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.43% and 0.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

4. Got $500? 3 Pharma Stocks to Buy and Hold Forever

   www.aol.com/got-500-3-pharma-stocks-141500043.html

   1. Vertex Pharmaceuticals. Vertex Pharmaceuticals (NASDAQ: VRTX) is worth buying today and holding forever because it has dominance in one of its core markets, cystic fibrosis (CF) therapies. This ...

5. List of largest biomedical companies by revenue - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...

6. Fortune Global 500 - Wikipedia

   en.wikipedia.org/wiki/Fortune_Global_500

   Insurance: Life, Health (Stock) AXA France: 27 149,461 Insurance: Property & Casualty (Mutual) State Farm Insurance United States: 95 78,331 Insurance: Property & Casualty (Stock) Berkshire Hathaway United States: 10 242,137 Internet Services & Retailing Amazon.com United States: 18 177,866 Mail, Package, & Freight Delivery China Post Group ...

7. Pfizer - Wikipedia

   en.wikipedia.org/wiki/Pfizer

   BYU was originally seeking a 15% royalty on sales, equating to $9.7 billion. A research agreement had been made between BYU and Monsanto, whose pharmaceutical business was later acquired by Pfizer, to develop a better aspirin. The enzyme Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal ...

8. Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over ...

   www.aol.com/billionaires-buying-beaten-down...

   A buy for risk-averse investors. Pfizer offers a 5.9% dividend yield at recent prices. It's been able to raise its dividend payout every year since 2009, and steady raises in the years ahead ...

9. R-Pharm - Wikipedia

   en.wikipedia.org/wiki/R-Pharm

   R-Pharm logo. R-Pharm (Russian: Р-Фарм) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection.